Bronchial Thermoplasty in Severe Persistent Asthma

Conditions

Severe Asthma

What is the purpose of this trial?

As Conditions of Approval of the PMA for the Alair System, the FDA requires Asthmatx to generate data to assess the durability of the BT treatment effect as well as safety data in the intended use population in the United States.



Participation Guidelines

Age:
18 Years - 65 Years
Gender:
Both

Click here for detailed information about who can participate in this trial.


Sponsor:
Asthmatx, Inc.
Boston Scientific Corporation
Dates:
April 2011
Last Updated:
February 26, 2014
Study HIC#:

Clinicaltrials.gov ID: NCT01350336